Search Results
Sofinicline 5mg 5mg | Purity Not Available
Adooq Bioscience
Sofinicline is a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.
More Information Supplier PageSofinicline 10mg 10mg | Purity Not Available
Adooq Bioscience
Sofinicline is a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.
More Information Supplier PageMeisoindigo 5mg 5mg | Purity Not Available
Adooq Bioscience
Meisoindigo, a derivative of Indigo naturalis, is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
More Information Supplier PageMeisoindigo 25mg 25mg | Purity Not Available
Adooq Bioscience
Meisoindigo, a derivative of Indigo naturalis, is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
More Information Supplier PageMeisoindigo 10mg 10mg | Purity Not Available
Adooq Bioscience
Meisoindigo, a derivative of Indigo naturalis, is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.
More Information Supplier PageClobetasol 50mg 50mg | Purity Not Available
Adooq Bioscience
Clobetasol is a topical corticosteroid, glucocorticoid, and antiinflammatory.
More Information Supplier PageClobetasol 25mg 25mg | Purity Not Available
Adooq Bioscience
Clobetasol is a topical corticosteroid, glucocorticoid, and antiinflammatory.
More Information Supplier PagePX 12 25mg 25mg | Purity Not Available
Adooq Bioscience
PX 12 inhibits hypoxia-induced HIF-1a transcriptional activity (IC50 11 nM) and proliferation of HT29 and MCF-7 tumor cells (IC50 1.9 and 0.9 uM, respectively).
More Information Supplier PagePX 12 100mg 100mg | Purity Not Available
Adooq Bioscience
PX 12 inhibits hypoxia-induced HIF-1a transcriptional activity (IC50 11 nM) and proliferation of HT29 and MCF-7 tumor cells (IC50 1.9 and 0.9 uM, respectively).
More Information Supplier Page